Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial testing the use of umbilical cord-derived mesenchymal stem cells as adjuvant therapy for chronic obstructive pulmonary disease (COPD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: RSUP Persahabatan | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: RECRUITING